Encompass Health (EHC) executive compensation, 2026 proxy

Mark J. Tarr, President and Chief Executive Officer, was paid $10.3M in 2025, up 11% from $9.3M the year before. The CEO-to-median-employee pay ratio was 203:1, on median employee pay of $50,647.

Filed
April 7, 2026
Annual meeting
May 7, 2026
Pay year
2025
Named executives
5
CEO total pay
$10.3M+11% vs prior year
CEO to median employee
203:1median $50,647
CEO pay in equity
63%$6.5M in awards
Prior say-on-pay support
93%of votes cast
CEO Stock Awards
$5,285,381Granted as performance and time-based shares
CEO Option Awards
$1,165,376Stock options granted in 2025
CEO Non-Equity Incentive
$2,581,525Earned under bonus plan
CEO Pay Ratio
203:1Compared to median employee pay

How Tarr was paid

$10.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary11%Stock awards51%Option awards11%Non-equity incentive25%All other compensation2%

Named executive officers

ExecutiveTotal
Mark J. TarrPresident and Chief Executive Officer$10,297,258
Patrick W. TuerExecutive Vice President and Chief Operating Officer$2,843,388
Douglas E. ColtharpExecutive Vice President and Chief Financial Officer$4,521,171
Patrick DarbyExecutive Vice President, General Counsel and Secretary$2,682,106
Elissa J. CharbonneauChief Medical Officer$1,444,583

What changed and why

  • $10.3MCEO Mark J. Tarr received total compensation of $10,297,258 in 2025, representing an increase from $9,301,929 in 2024.
  • 93%The company has received a say-on-pay approval vote of greater than 93% every year.
  • Annual and long-term incentive plans include multiple performance measures such as financial and sustainability metrics.
  • 50%Stock ownership guidelines require executives to retain 50% of net shares until ownership multiples are met.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.